Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1996 2
1999 2
2000 1
2001 1
2003 2
2004 1
2005 3
2006 5
2007 7
2008 2
2009 4
2010 7
2011 8
2012 6
2013 8
2014 6
2015 8
2016 3
2017 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: o connor pw. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Polman CH, et al. Among authors: o connor pw. N Engl J Med. 2006 Mar 2;354(9):899-910. doi: 10.1056/NEJMoa044397. N Engl J Med. 2006. PMID: 16510744 Free article. Clinical Trial.
Teriflunomide.
Oh J, O'Connor PW. Oh J, et al. Among authors: o connor pw. Neurol Clin Pract. 2013 Jun;3(3):254-260. doi: 10.1212/CPJ.0b013e318296f299. Neurol Clin Pract. 2013. PMID: 23914327 Free PMC article.
Teriflunomide for the treatment of multiple sclerosis.
Oh J, O'Connor PW. Oh J, et al. Among authors: o connor pw. Semin Neurol. 2013 Feb;33(1):45-55. doi: 10.1055/s-0033-1343795. Epub 2013 May 25. Semin Neurol. 2013. PMID: 23709212 Review.
Disease-modifying agents in multiple sclerosis.
O'Connor PW, Oh J. O'Connor PW, et al. Handb Clin Neurol. 2014;122:465-501. doi: 10.1016/B978-0-444-52001-2.00021-2. Handb Clin Neurol. 2014. PMID: 24507532 Review.
Natalizumab and other monoclonal antibodies.
Ursell MR, O'Connor PW. Ursell MR, et al. Among authors: o connor pw. Neurol Clin. 2005 Feb;23(1):233-46, viii. doi: 10.1016/j.ncl.2004.09.005. Neurol Clin. 2005. PMID: 15661096 Review. No abstract available.
75 results